Abstract
BackgroundMethotrexate is the cornerstone of treatment of RA1. However, major drawbacks of MTX therapy are the large interpatient variability in clinical response and unpredictable appearance of a large spectrum of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
